Search

Your search keyword '"Antiviral agents -- Product introduction"' showing total 91 results
Start Over Descriptor "Antiviral agents -- Product introduction"
91 results on '"Antiviral agents -- Product introduction"'

1. New COVID-19 treatment from Merck could reduce hospitalizations and deaths

Subjects
Merck & Company Inc. -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, General interest
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/transcript/transcript.php?storyId=1042667282 BYLINE: JOE PALCA HOST: SCOTT SIMON SCOTT SIMON: The United States has seen another grim mark in this pandemic. More than 700,000 [...]

Published
2021

3. Germ-O-Guard launches line of innovative new anti-viral and anti-bacterial consumer products

Subjects
Consumer goods -- Product introduction, Antiviral agents -- Product introduction, Antibacterial agents -- Product introduction, Banking, finance and accounting industries
Abstract

(PRWeb) - Germ-O-Guard is launching a crowdfunding campaign to introduce its line of anti-viral and anti-bacterial products to the market. Germ-O-Guard products are made from materials with self-sterilizing properties, making [...]

Published
2022

4. Germ-O-Guard launches line of innovative new anti-viral and anti-bacterial consumer products

Subjects
Consumer goods -- Product introduction, Antiviral agents -- Product introduction, Antibacterial agents -- Product introduction, Business, general
Abstract

BOYNTON BEACH, Fla. (PRWEB) April 20, 2022 Germ-O-Guard is launching a crowdfunding campaign to introduce its line of anti-viral and anti-bacterial products to the market. Germ-O-Guard products are made from [...]

Published
2022

5. Germ-O-Guard launches line of innovative new anti-viral and anti-bacterial consumer products

Subjects
Consumer goods -- Product introduction, Antiviral agents -- Product introduction, Antibacterial agents -- Product introduction, Business, News, opinion and commentary
Abstract

Germ-O-Guard anti-viral and anti-bacterial products include face masks, phone, tablet and computer protector skins, handkerchiefs & scarves, adhesive sheets, and rolls of film for custom applications and DiY projects. Using [...]

Published
2022

6. Lactoferrin Market Size to Reach $395.75 million by 2030 - Latest Developments in Nutrition and Health Sector, New Product Launch, Expansion Plans and Future Outlook: The Brainy Insights

Subjects
Infant formulas -- Product introduction, Antiviral agents -- Product introduction, Toiletries industry -- Product introduction, Dietary supplements -- Product introduction, Antifungal agents -- Product introduction, Lactoferrins, Banking, finance and accounting industries, Business
Abstract

Dallas, Feb 02, 2022 (GLOBE NEWSWIRE via COMTEX) -- As per the report published by The Brainy Insights, the global lactoferrin market is expected to grow from USD 142.47 million [...]

Published
2022

7. Lanxess Introduces Virkon S effective for African Swine Fever Biosecurity

Subjects
LANXESS Corp. -- Product introduction, Antiviral agents -- Product introduction, Chemical industry -- Product introduction, Hog cholera -- Care and treatment, Arts and entertainment industries
Abstract

With African Swine Fever (ASF) currently threatening indigenous livestock in Eastern and Central Europe, specialty chemicals company Lanxess said it is offering swine producers the broad spectrum virucidal disinfectant Virkon [...]

Published
2018

8. Fitesa Launches Anti-Viral Product Line

Subjects
Cintas Corp. -- Product introduction -- Officials and employees, Antiviral agents -- Product introduction, Nonwoven fabrics -- Product introduction, Coronaviruses, Business, Fashion, accessories and textiles industries
Abstract

Following a series of investments designed to help in the fight against Covid-19, nonwovens producer Fitesa has expanded its product line to include an antiviral product line with a material [...]

Published
2021

9. United States : Trump EPA Approves First-Ever Long-Lasting Antiviral Product for Use Against COVID-19

Subjects
United States. Environmental Protection Agency, American Airlines Inc. -- Product introduction, Coronaviruses -- Health aspects, Antiviral agents -- Product introduction, Government agencies -- Health aspects, COVID-19 -- Health aspects, Business, international
Abstract

U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler announced a groundbreaking development in the Trump Administrations efforts to combat the novel coronavirus. In a first-of-its kind step, EPA has issued [...]

Published
2020

10. TRUMP EPA APPROVES FIRST-EVER LONG-LASTING ANTIVIRAL PRODUCT FOR USE AGAINST COVID-19

Subjects
United States. Environmental Protection Agency -- Environmental aspects, American Airlines Inc. -- Product introduction, Antiviral agents -- Product introduction, Coronaviruses -- Health aspects -- Environmental aspects, Government agencies -- Environmental aspects -- Health aspects, COVID-19 -- Environmental aspects -- Health aspects, News, opinion and commentary
Abstract

WASHINGTON -- The following information was released by the U.S. Environmental Protection Agency (EPA): Today, U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler announced a groundbreaking development in the Trump [...]

Published
2020

11. 10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19

Subjects
Vaccines -- Product introduction, Antiviral agents -- Product introduction, Autoimmunity, COVID-19, Business, international, Law
Abstract

(GlobeNewswire) - 10x Genomics(Nasdaq: TXG) strengthened the research toolkit of scientists around the globe today with the launch of its Chromium Single Cell Immune Profiling v2 product. The new product [...]

Published
2020

12. 10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19

Subjects
Vaccines -- Product introduction, Antiviral agents -- Product introduction, Autoimmunity, COVID-19, Banking, finance and accounting industries, Business
Abstract

PLEASANTON, Jul 14, 2020 (GLOBE NEWSWIRE via COMTEX) -- 10x Genomics (Nasdaq: TXG) strengthened the research toolkit of scientists around the globe today with the launch of its Chromium Single [...]

Published
2020

13. New Novel Germicidal and Anti-Viral Products from Thin Air Energy(TM)

Subjects
Light-emitting diodes -- Product introduction, Antiviral agents -- Product introduction, Business, News, opinion and commentary
Abstract

TORCH UVc(TM) and GEIGER UVc(TM) Utilize Science-Based Research Proven to Kill Germs and Virus WICHITA, Kan., June 3, 2020 /PRNewswire/ -- Thin Air Energy(TM), a leader in energy storage and [...]

Published
2020

14. Lab-Validated Anti-Microbial Solution Now Available for All MetroClick|faytech NA Digital Signage, Kiosks and Touchscreen Hardware

Subjects
Antiviral agents -- Product introduction, Signage -- Product introduction, Kiosks -- Product introduction, Hospitality industry -- Officials and employees -- Product introduction, Displays (Marketing) -- Product introduction, Technology, Antibacterial agents, Service industries, Health, Production management, General interest, News, opinion and commentary
Abstract

NEW YORK: MetroClick/faytech NA has issued the following press release: As retail, restaurants, hospitality and other service industries start reopening across the U.S. and Canada, customer health and safety is [...]

Published
2020

15. AUM LifeTech and AUM BioTech Launch 'Knockdown Coronavirus'

Subjects
Coronavirus infections -- Care and treatment, Biotechnology, Antiviral agents -- Product introduction, Biotechnology industry -- Product introduction, RNA, Coronaviruses, Business, News, opinion and commentary
Abstract

Philadelphia-based Initiative Will Facilitate SARS-CoV-2 Research to Develop Antiviral Therapy for COVID-19 Using RNA Silencing FANA ASO Technology PHILADELPHIA, May 5, 2020 /PRNewswire/ -- The coronavirus pandemic has significantly disrupted [...]

Published
2020

16. Korean Firm HAAN Corporation Launches Breakthrough Antiviral Protection Globally

Subjects
Antiviral agents -- Product introduction, Backup software, Infection, Safety equipment, Protective devices, General interest, News, opinion and commentary
Abstract

SEOUL: HAAN Corporation has issued the following news release: Korean lifestyle product company HAAN Corporation announced that it will launch an unprecedented antiviral formula in South Korea on April 28, [...]

Published
2020

17. Korean Firm HAAN Corporation Launches Breakthrough Antiviral Protection Globally

Subjects
Antiviral agents -- Product introduction, Business, News, opinion and commentary
Abstract

SEOUL, South Korea, April 27, 2020 /PRNewswire/ -- Korean lifestyle product company HAAN Corporation announced that it will launch an unprecedented antiviral formula in South Korea on April 28, along [...]

Published
2020

18. New product information wording - Extracts from PRAC recommendations on signals Adopted at the 1-4 October 2018 PRAC

Subjects
Glecaprevir -- Product introduction, Pibrentasvir -- Product introduction, Norelgestromin, Dienogest, Antiviral agents -- Product introduction, Conjugated estrogens -- Product introduction, Dolutegravir, Etonogestrel, Teriflunomide, Voxilaprevir -- Product introduction, Protease inhibitors -- Product introduction, Drospirenone -- Product introduction, Risk assessment, Web sites (World Wide Web), Business, international
Abstract

Amsterdam: European Medicines Agency has issued the following document: 30 Churchill Place * Canary Wharf * London E14 5EU * United Kingdom An agency of the European Union Telephone +44 [...]

Published
2019

19. Selected new drugs of 1996

Author

Hussar, Daniel A.

Subjects
Antiviral agents -- Product introduction, Anti-infective agents -- Product introduction, Hypoglycemic agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Health care industry, Retail industry, Product introduction
Abstract

A review of agents that treat HIV, infection, diabetes and ALS In this second part of a two-part series on selected new drugs that have been marketed in 1996, the [...]

Published
1996

20. Fujifilm's role in Ebola fight captures hope in a snapshot

Subjects
FUJIFILM Corp. -- Product introduction, Ebola virus infections -- Care and treatment -- Drug therapy, Antiviral agents -- Product introduction, Photographic industry -- Product introduction, International relations, Political science, Avigan (Medication) -- Product introduction
Abstract

When the Ebola outbreak of 2014 presented a significant threat to global security and killed thousands of people, panic started to set in. There were no drugs on the market [...]

Published
2016

21. FDA approves addition of new warnings to hep C drug label

Author

Talsma, Julia

Subjects
Antiviral agents -- Product introduction, Simeprevir -- Product introduction, Business, Pharmaceuticals and cosmetics industries
Abstract

FDA has approved label changes for the hepatitis C antiviral simeprevir (Olysio; Janssen) that will include new warnings about serious symptomatic bradycardia--slowing of the heart rate--when the drug is coadministered [...]

Published
2015

22. Clinical News: Treatment launched for hepatitis

Subjects
Novartis Pharma AG -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Hepatitis B -- Drug therapy, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries, Sebivo (Medication) -- Product introduction
Abstract

Novartis Pharmaceuticals has launched a treatments for hepatitis B. Telbivudine (Sebivo) is licensed for the treatment of chronic hepatitis B in adults with compensated liver disease, evidence of viral replication, [...]

Published
2007

23. OVER THE COUNTER: New prescription product - Emtriva oral solution

Subjects
Gilead Sciences Inc. -- Product introduction, Biological products industry -- Product introduction, Anti-HIV agents -- Product introduction, Antiviral agents -- Product introduction, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

Liquid containing emtricitabine 10mg/ml For use in HIV-1 infections or in combination with other anti- retrovirals Usual dose: 240mg (24ml) once daily in adults and 6mg/kg (up to 240mg) in [...]

Published
2005

24. Telzir Oral Suspension

Subjects
GlaxoSmithKline PLC -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

GlaxoSmithKline has launched Telzir (fosamprenavir) 50mg/ml Oral Suspension. It is licensed in combination with low dose ritonavir for the treatment of HIV in adults over 18 years old. It should [...]

Published
2004

25. Emtriva for HIV

Subjects
Gilead Sciences Inc. -- Product introduction, AIDS patients -- Drug therapy, Antiviral agents -- Product introduction, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries, Emtriva (Medication) -- Product introduction
Abstract

Gilead has launched a new nucleoside and nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infected adults and children in conjunction with other antiretroviral agents. Emtriva (emtricitabine 200mg capsules) [...]

Published
2003

26. New Drugs 2001 Part III

Author

HUSSAR, DANIEL A.

Subjects
Pharmaceutical industry -- Product introduction, Anticoagulants (Medicine) -- Product introduction, Antiviral agents -- Product introduction, Abortifacients -- Product introduction, Antineoplastic agents -- Product introduction, Local anesthesia -- Product introduction, Anticholesteremic agents -- Product introduction, Health
Published
2001

27. NEW DRUGS

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Organon Inc. -- Product introduction -- Laws, regulations and rules, Salix Pharmaceuticals -- Product introduction, Axcan Scandipharm Inc. -- Product introduction, Schering-Plough Corp. -- Product introduction -- Laws, regulations and rules, Enzon Pharmaceuticals Inc. -- Product introduction -- Laws, regulations and rules, Hepatitis -- Laws, regulations and rules, Antiviral agents -- Product introduction, Contraceptives industry -- Product introduction, Pharmaceutical industry -- Product introduction, Oral contraceptives -- Product introduction, Government regulation, Business, Pharmaceuticals and cosmetics industries, Cyclessa (Contraceptive) -- Product introduction, Colazal (Medication) -- Product introduction, Canasa (Medication) -- Product introduction, Peg-Intron (Medication) -- Product introduction
Abstract

Organon Inc., West Orange, N.J., (800) 241-8812, has received FDA approval for Cyclessa (desogestrel/ethinyl estradiol oral contraceptive), the first low-dose (less than 30 mcg of estrogen) triphasic contraceptive. Cyclessa is [...]

Published
2001

28. UK drug update

Subjects
Novo Nordisk Pharmaceuticals Inc. -- Product introduction, Janssen-Cilag -- Product introduction, Sanofi Winthrop GmbH -- Product introduction, Dermal Laboratories Ltd. -- Product introduction, Ferring Pharmaceuticals -- Product introduction, Organon Laboratories (UK) -- Product introduction, Rosemont Pharmaceutical Corp. -- Product introduction, Abbott Laboratories (Abbott Park, Illinois) -- Product introduction, Product introduction, Hormones, Antiviral agents -- Product introduction, Hypoglycemic agents, Respiratory system agents, Contraceptives industry -- Product introduction, Pharmaceutical industry -- Product introduction, Contraceptives -- Product introduction, Respiratory agents
Abstract

Novo Nordisk Pharmaceuticals has introduced Novorapid injections. The vials, Penfill cartridges and Novolet prefilled syringe contain insulin aspart 100 units/ml. Dermal Laboratories has brought out an antimicrobial bath emollient. The [...]

Published
1999

29. INNOVATIONS

Subjects
Trimeris Inc. -- Product introduction, Pharmaceutical industry -- Innovations, Antiviral agents -- Product introduction, Antibiotics -- Product defects and recalls
Published
1999

30. New Rescriptor Pills

Subjects
Pharmacia & Upjohn Inc. -- Product introduction, Rescriptor (Medication) -- Product introduction, Antiviral agents -- Product introduction
Abstract

Rescriptor (delavirdine mesylate), indicated for the treatment of HIV infections in combination with antiretroviral agents, is now available in a 200-mg tablet size. The new tablets are smaller than the [...]

Published
1999

31. From antivirals to Viagra: drug review of '98

Subjects
Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Antibacterial agents -- Product introduction, Cardiovascular agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries
Published
1999

33. New edition of WHO prequalification list to include four new anti-aids medicines

Subjects
Lamivudine -- Product introduction, Antiviral agents -- Product introduction, Anti-HIV agents -- Product introduction, Pharmaceutical industry -- Product introduction, Health, Science and technology, Product introduction
Abstract

Four new AIDS medicines are being added to the World Health Organization (WHO) prequalification list, thus further increasing access to a choice of quality products. At the same time, product [...]

Published
2004

34. Companies sock away swine meds; Exelon among firms loading up on anti-virals

Author

Colias, Mike and Saphir, Ann

Subjects
Exelon Corp. -- Product introduction, Antiviral agents -- Product introduction, Swine influenza -- Control, Pharmaceutical industry -- Product introduction, Business, Business, regional
Abstract

Fearing a flu pandemic, some Chicago companies are stockpiling influenza-fighting drugs. Exelon Corp. has stashed thousands of doses of anti-viral medications such as Tamiflu for employees and their dependents in [...]

Published
2009

35. New drugs of 1986

Author

Hussar, Daniel A.

Subjects
Drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Pediculosis -- Care and treatment, Antiviral agents -- Product introduction, Anti-arrhythmia drugs -- Product introduction, New products -- Analysis, Business, Health care industry, Pharmaceuticals and cosmetics industries, Retail industry
Published
1986

36. A new drug for chronic hepatitis B in adults

Author

Aschenbrenner, Diane S.

Subjects
Hepatitis B -- Drug therapy, Antiviral agents -- Product introduction, Health, Tyzeka (Medication) -- Product introduction
Published
2007

37. Marinomed Biotechnologie GmbH's antiviral spray fights cold in Canada

Subjects
Antiviral agents -- Product introduction, Business, Chemicals, plastics and rubber industries
Abstract

An innovative nasal spray that has been proven clinically effective against respiratory viruses has now been authorized for the Canadian market. The product, which was developed by the Viennese biotech [...]

Published
2013

38. South Africa's Aspen unveils anti-AIDS drug

Subjects
Aspen Pharmacare Holdings Ltd. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Generic drugs -- Product introduction, Business, Business, general
Published
2003

39. New antivirals would increase options but confuse physicians

Subjects
Didanosine -- Product introduction, Antiviral agents -- Product introduction, HIV infection -- Drug therapy, Zalcitabine -- Product introduction, AIDS (Disease) -- Drug therapy, Health
Abstract

Now that the manufacturers of two experimental antivirals have taken steps toward winning approval from the federal Food and Drug Administration, physicians and patients may soon have treatment options on [...]

Published
1991

40. Africa has now begun to manufacture generic AIDS drugs

Subjects
Aspen Pharmacare Holdings Ltd. -- Product introduction, Antiviral agents -- Product introduction, Anti-HIV agents -- Product introduction, Family and marriage, Health, Product introduction
Abstract

Africa has now begun to manufacture generic AIDS drugs. The South African company Aspen Pharmacare announced it is producing antiretrovirals containing stavudine--the generic version of Bristol-Meyers Squibb's Zerit. One month's [...]

Published
2003

42. New products in 1994

Author

Hughes, Susan

Subjects
Genentech Inc. -- Product introduction, Roche Holding Ltd. -- Product introduction, Pfizer Inc. -- Product introduction, Upjohn Co. -- Product introduction, Hoechst AG -- Product introduction, Cystic fibrosis -- Drug therapy, Rheumatoid arthritis -- Drug therapy, Subarachnoid hemorrhage -- Drug therapy, Antidepressants -- Product introduction, Alzheimer's disease -- Drug therapy, Antiviral agents -- Product introduction, Immunosuppressive agents -- Product introduction, Antineoplastic agents -- Product introduction, Cardiovascular agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Pulmozyme (Medication) -- Product introduction, Tenidap (Medication) -- Product introduction, Freedox (Medication) -- Product introduction, Velnacrine (Medication) -- Product introduction
Published
1994

43. Cold sores affect millions

Author

Cassell, Dana K.

Subjects
Cold sores -- Causes of, Cold sores -- Drug therapy, Herpes simplex -- Causes of, Herpes simplex -- Drug therapy, Antiviral agents -- Product introduction, Herpes simplex virus -- Health aspects, Herpes simplex virus -- Research, Pharmaceutical industry -- Product introduction
Abstract

In ancient Rome, an epidemic of cold sores (also known as fever blisters) prompted Emperor Tiberius to ban kissing in public ceremonies. Today, cold sores continue to present in epidemic [...]

Published
2009

44. Reese rollout

Subjects
Reese Pharmaceutical Co. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry, OneTab (Medication) -- Product introduction
Abstract

Reese Pharmaceutical Co. has introduced a line of three O-T-C dye-flee cold- and flu-relief tablet products. Marketed under the brand name OneTab, the individual product offerings are for cold and [...]

Published
2009

45. Roche says that supplies of Tamiflu are adequate

Subjects
Hoffmann-La Roche Inc. -- Product introduction -- Company forecasts, Antiviral agents -- Product introduction, Pharmaceutical industry -- Company forecasts -- Product introduction, Company business forecast/projection, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

Hoffman-La Roche Inc. asserts that its Tamiflu antiviral flu medication will be in ample supply for the 2008/09 flu season. The product, known by its generic name of oseltamivir phosphate, [...]

Published
2008

46. Roche

Subjects
Roche Holding AG -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry, Tamiflu (Medication) -- Product introduction
Abstract

Ample supplies of the flu medication Tamiflu will be available throughout the United States during flu season, manufacturer Roche stated. The Centers for Disease Control and Prevention has cited Tamiflu [...]

Published
2008

47. Lexiva oral suspension

Subjects
GSK PLC -- Product introduction, Antiviral agents -- Product introduction, Fosamprenavir -- Product introduction, Pharmaceutical industry -- Product introduction, Health, Lexiva (Medication) -- Product introduction
Abstract

An oral suspension formulation of GlaxoSmithKline's protease inhibitor Lexiva (fosamprenavir calcium) has been made available for the treatment of patients 2-18 years of age infected with HIV. The 50mg/mL strength [...]

Published
2007

48. Atripla™ (efavirenz 600 mg, emtricitabine 200 mg, and tenofovir disoproxil fumarate 300 mg)

Subjects
Bristol-Myers Squibb Co. -- Research agreements -- Product introduction, Gilead Sciences Inc. -- Research agreements -- Product introduction, Biological products industry -- Research agreements -- Product introduction, Antiviral agents -- Product introduction, Anti-HIV agents -- Product introduction, Pharmaceutical industry -- Research agreements -- Product introduction, Health, Atripla (Medication) -- Product introduction
Abstract

Bristol-Myers Squibb Company and Gilead Sciences, Inc Atripla combines two already-approved products--Bristol-Myers Squibb's Sustiva® and Gilead Science's Truvada®--in the first once-daily, single-dose regimen for the treatment of HW-1 in adults. [...]

Published
2006

49. Abbott urged to provide new version of Kaletra to poor countries

Subjects
Abbott Laboratories (Abbott Park, Illinois) -- Product enhancement, Abbott Laboratories (Abbott Park, Illinois) -- International marketing, Alternative medicine -- International marketing, Antiviral agents -- Product introduction, Antiviral agents -- International marketing, Pharmaceutical industry -- Product introduction, Pharmaceutical industry -- International marketing, Product enhancement, Business, Pharmaceuticals and cosmetics industries
Abstract

A non-governmental organization, Medecins sans Frontieres, has asked Abbott Laboratories to introduce a new version of its antiretroviral drug, Kaletra (lopinavir plus ritonavir) for sale in poor and developing countries.

Published
2006

50. PS debut

Subjects
Antibacterial agents -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

American HomeHealth Inc. has created an 'infection prevention' category with its debut of PS. The brand incorporates a number of antiviral and antibacterial products to help consumers with their cleaning [...]

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results